Novartis Ag (NVS) EPS (Diluted) (2009 - 2026)
Novartis Ag (NVS) posted EPS (Diluted) of $1.67 for Q2 2026, down 15.9% from $1.99 a year earlier and down 11.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) EPS (Diluted) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Novartis Ag was $8.07, down 9.6% year-over-year; for FY2025, it was $7.15, up 8.4% from FY2024.
- Annual EPS (Diluted) shows a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
- In prior years, Novartis Ag's EPS (Diluted) was $6.60 in FY2024 (-7.1%), $7.10 in FY2023 (+124.2%), $3.17 in FY2022 (-70.2%) and $10.63 in FY2021 (+202.3%).
- Quarterly EPS (Diluted) has run from a low of $0.67 in Q4 2022 to a high of $7.22 in Q4 2021 over five years.
- On a year-over-year basis, EPS (Diluted) increased in five of the last eight quarters, with growth averaging 33.9%.
- The strongest year-over-year quarter for EPS (Diluted) in the past five years was Q4 2021, with growth of 689.2%; the weakest was Q4 2022, with a decline of 90.8%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was $1.88 (Q1 2026), $1.16 (Q4 2025) and $3.23 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 0.56 |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 2.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 |
| Mar 31, 2026 | 1.88 |
| Dec 31, 2025 | 1.16 |
| Sep 30, 2025 | 3.23 |
| Jun 30, 2025 | 1.99 |
| Mar 31, 2025 | 1.79 |
| Dec 31, 2024 | 2.06 |
| Sep 30, 2024 | 3.00 |
| Jun 30, 2024 | 1.55 |
| Mar 31, 2024 | 1.08 |
| Dec 31, 2023 | 4.05 |
| Sep 30, 2023 | 0.80 |
| Jun 30, 2023 | 1.05 |
| Mar 31, 2023 | 1.04 |
| Dec 31, 2022 | 0.67 |
| Sep 30, 2022 | 0.70 |
| Jun 30, 2022 | 0.75 |
| Mar 31, 2022 | 0.98 |
| Dec 31, 2021 | 7.22 |
| Sep 30, 2021 | 1.20 |
API Access
Novartis Ag EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();